| Year |
Citation |
Score |
| 2023 |
Hommen P, Hwang J, Huang F, Borgelt L, Hohnen L, Wu P. Chromenopyrazole-peptide conjugates as small-molecule based inhibitors disrupting the protein-RNA interaction of LIN28-let-7. Chembiochem : a European Journal of Chemical Biology. e202300376. PMID 37224100 DOI: 10.1002/cbic.202300376 |
0.43 |
|
| 2023 |
Borgelt L, Huang F, Hohnen L, Qiu X, Goebel GL, Hommen P, Wu P. Spirocyclic Chromenopyrazole Inhibitors Disrupting the Interaction between the RNA-binding protein LIN28 and Let-7. Chembiochem : a European Journal of Chemical Biology. e202300168. PMID 37129525 DOI: 10.1002/cbic.202300168 |
0.483 |
|
| 2020 |
Huang F, Hu H, Wang K, Peng C, Xu W, Zhang Y, Gao J, Liu Y, Zhou H, Huang R, Li M, Shen J, Xu Y. Identification of Highly Selective Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitors by a Covalent-Fragment-Based Approach. Journal of Medicinal Chemistry. PMID 32459096 DOI: 10.1021/Acs.Jmedchem.0C00372 |
0.315 |
|
| 2019 |
Huang F, Ning M, Wang K, Liu J, Guan WB, Leng Y, Shen J. Discovery of Highly Polar β-homophenylalanine Derivatives as Non-systemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors. Journal of Medicinal Chemistry. PMID 31747282 DOI: 10.1021/acs.jmedchem.9b01649 |
0.303 |
|
| 2017 |
Liu Q, Huang F, Yuan X, Wang K, Zou Y, Shen J, Xu Y. Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2. Journal of Medicinal Chemistry. PMID 29193967 DOI: 10.1021/acs.jmedchem.7b01530 |
0.397 |
|
| 2017 |
Liu Q, Huang F, Yuan X, Wang K, Zou Y, Shen J, Xu Y. Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2. Journal of Medicinal Chemistry. PMID 29193967 DOI: 10.1021/acs.jmedchem.7b01530 |
0.397 |
|
| Show low-probability matches. |